AIIMS Bhopal signed an MoU with CSIR-CCMB to tackle Sickle Cell Disease.

CNN Central News & Network–ITDC India Epress/ITDC News Bhopal: AIIMS Bhopal has signed a Memorandum of Understanding (MoU) with the Council of Scientific and Industrial Research and the Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, to address sickle cell disease and related genetic disorders. This collaboration is a significant step towards enhancing diagnostic capabilities and research initiatives, especially in Central India, to tackle the challenges posed by sickle cell disease.

AIIMS Bhopal Executive Director Ajay Singh stated, “Our collaboration with CSIR-CCMB is a crucial step towards improving diagnostic capabilities for sickle cell disease. With the introduction of this PCR-based test, we will be able to offer accurate diagnoses, particularly in underserved communities, leading to significant improvements in patient care.” He also mentioned that the test is currently in the early validation phase and will be used in comparison mode with other government-approved tests.

A key aspect of this partnership is the implementation of a molecular PCR-based diagnostic test developed by CSIR-CCMB, which will be introduced at AIIMS Bhopal. This advanced diagnostic tool will provide opportunities for quick and accurate diagnoses, significantly improving the management of sickle cell disease.

The molecular PCR-based test developed by CSIR-CCMB allows for the rapid and precise genetic identification of sickle cell mutations. Giriraj Chandak, the mission lead of the Sickle Cell Anemia Mission at CSIR-CCMB, said, “This MoU is a critical milestone for our mission, which aims to bring scientific advancements to those who need it the most. Through this partnership, the PCR-based test we have developed can now benefit countless patients, advancing diagnostic and research capabilities in sickle cell disease.”

In addition to implementing the PCR-based test, this collaboration will support joint research projects on sickle cell disease and genetic health. The partnership aims to foster advancements in genetic research, enhance diagnostic understanding, and make meaningful contributions to public health.

#AIIMSBhopal #CSIRCCMB #SickleCellDisease #MedicalResearch